Targeting IL13Ra2-expressing diffuse midline glioma with specific immunotoxin therapy attenuates DNA-damage response and dramatically increases radiation mediated cell death, significantly improving survival.
- Julian S. Rechberger
- Wouter J. F. Vanbilloen
- David J. Daniels